(Total Views: 491)
Posted On: 09/11/2025 12:29:56 AM
Post# of 156888
Re: Evil Rabbit #156828
It will be interesting to see if the dosage safety review in the CRC trial and the open label monitoring of PD-L1 that Hoffman was so clear about today, gives a TNBC trial the basis to make the previous medical advances of the ages look like childs play.
(2)
(0)
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
